Global Industry Analysts, Inc. (GIA) launches comprehensive analysis of industry segments, market trends, growth drivers, market share, size and demand forecasts on the global Cell Harvesting market. Market segmentation includes Application (Peripheral Blood, Bone Marrow, Umbilical Cord, Adipose Tissue, and Other Applications).
The global cell harvesting market is anticipated to exhibit a robust growth in the long term on account of increasing investments in clinical, cell-based and regenerative medicine research. The technique is likely to gain from rising incidence of infectious and chronic diseases coupled with continuous expansion of the biotechnology and biopharmaceutical industries. The US is expected to dominate the global cell harvesting market and account for the leading share in the coming years. The regional market is dominated by the US due to increasing R&D investments and favorable government policies. The US FDA has approved cord blood-based blood-forming stem cells for use in the US. These cells along with stem cells derived from the bone marrow are widely used in medical transplant procedures for treatment of cancer along with diseases related to the immune system and blood. The US market is also bolstered by increasing healthcare expenditure in the country. While Europe is anticipated to secure the second-leading position, the Asia-Pacific region is estimated to exhibit the fastest growth rate. The regional market is driven by increasing R&D spending to develop new treatments, government policies favoring stem cell research, and public-private efforts to foster stem cell-based treatments. The Asia-Pacific market is likely to also gain from expansion of leading players across emerging economies in the region.
This latest edition of the research study is conducted and published by Global Industry Analysts, Inc., in close collaboration with senior executives in the industry driving strategy, business development, marketing, sales, product management, technology and operations. The views, opinions and findings presented are based on validated engagements from a total executive pool size of 24228. Among this pool, 2181 direct interactions with domain experts were carried out via our proprietary market research platform, MarketGlass. Among the 482 unique participations, a total of 63 validated responses were received as part of this report's primary research outreach program. We are unique in the industry to provide our clients with the validated list executive engagements and the complete project data stack.
Key Competitors Covered in the Report -
GE Healthcare Life Sciences
Terumo BCT, Inc.
Aspire Medical Innovation
Cox Scientific Ltd
Segments Covered in the Report -
Type (Manual, Automated)
Application (Peripheral Blood, Bone Marrow, Umbilical Cord, Adipose Tissue, Other Applications)
End-Use (Biotech & Biopharma Companies, Research Institutes, Other End-Uses)
Geographies Analyzed in the Report -
Rest of Europe
Rest of World.
For enquiries e-mail us at sales@strategyR.com .
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) (www.strategyr.com) is the world`s only influencer driven AI powered market research company. Serving more than 41,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for 33 years, offering the widest coverage of topics, geographic markets, competitive brands, and companies profiled.
Director, Corporate Communications
Global Industry Analysts, Inc.